Get started
JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS)JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS)JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS)

JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS)

No trades
See on Supercharts
Overview News
Ideas
Discussions Technicals Seasonals Bonds

DJNJ3 trade ideas

Johnson & Johnson Technical AnalysisWait Before buying - check if the support level will not be broken before buying, otherwise hold Fundamental Analysis Johnson & Johnson (NYSE:JNJ) began researching vaccine candidates in January, as soon as the COVID-19 sequence became available. A Phase 1 clinical trial of the novel coronavirus vaccine is planned for September, with data regarding safety and efficacy available by the end of the year. If all goes accordingly, the vaccine could be ready “for emergency use” in early 2021. As part of this commitment, Johnson & Johnson will scale up its manufacturing capacity in the U.S. and other countries in order to enable the supply of more than 1 billion doses of the vaccine when it is ready.
NYSE:JNJ
by Mauriello
Johnson & Johnson Trade Idea #JNJThere's an old saying that goes by "Sell in May, and go away until Labor Day" As #JNJ continues to make lower lows, by bias is shifting towards the bearish outlook. I know sometimes it's tough deciding when to close positions and lock-in profit because you fear you might miss out on the right opportunity to re-enter the trade. If that's the concern, what I suggest is to continue to manually trail a pending "Buy Limit" order above the highs of each candle. As the price continues to fall, continue to manually adjust the trailing pending buy limit. This way once price action makes that higher high, our trading platform will automatically execute our buy position from the pending buy limit order. If anyone has any questions, feel free to leave them in the comment section below. Trade Safe - Trade Well Warm Regards, Michael Harding
NYSE:JNJShort
by Michael_Harding
Buy JOHNSON&JOHNSON [NYSE: $JNJ] | 5.12.2020 | Eric ChoeMy name is Eric Choe. I am a professional trader with over 7 years of equities and cryptocurrency experience. I've worked at an energy trading company, a Fortune 500 company, and one of the top management consulting firms in the world. I left my high-paying salary as a management consultant in early 2018 for a career in investing and trading. I've been a full-time equities trader ever since. I give detailed analysis on TradingView. Over the past 7 years, I've dedicated my time and effort to helping others learn about the financial markets. All my ideas are for education purposes. There is a high-degree of risks involving leverage trading. Trade at your own risk. This is not financial advice
NYSE:JNJLong
by StockDweebs
JNJ: Bearish Breakdown Analysis 4H (Apr. 26)X FORCE GLOBAL ANALYSIS: Johnson & Johnson has shown great momentum in its small rally over the past few weeks. However, technicals demonstrate signs of prices having temporarily topped out. Technical Analysis - The first thing we spot is a textbook bearish divergence. - Prices form higher highs, while the Relative Strength Index (RSI) forms lower highs - The Moving Average Convergence Divergence (MACD) has formed a death cross, with increasing bearish histograms - We have broken down from the ascending parallel channel, and the support has now become resisance - Prices have been testing the upper resistance of the Bollinger bands, and a test of the lower support is highly likely - We have two price gaps on the 4H chart, waiting to get potentially filled - The volume is decreasing as bearish tensions increase What We Believe Although JNJ is a fundamentally sound stock, and still great for the long run, short term technicals demonstrate a potential downside. Trade Safe.
NYSE:JNJShort
by XForceGlobal